GlassScriptPhysician profile
Janice Tavares
NPI 1609428721
$16,729.07
in general payments reported to CMS, 2019-2025
61 companies · $4,891 in 2025
The $4,891 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,727 · 2022: $3,884 · 2023: $2,725 · 2024: $3,502 · 2025: $4,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $17.00 · Education: $5.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,095.07 |
| Consulting Fee | $17.00 |
| Education | $5.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,190.61 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,489.60 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $1,488.40 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,179.79 | 2022-2025 | |
| Amgen INC. | $926.31 | 2021-2025 | Repatha, Repatha, Otezla |
| Lilly USA, LLC | $911.91 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $900.87 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $820.59 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $643.65 | 2021-2025 | |
| Glaxosmithkline, LLC. | $602.98 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $602.83 | 2021-2025 | Verquvo, Belsomra, Steglatro |
| E.R. Squibb & Sons, L.L.C. | $523.70 | 2021-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $507.63 | 2022-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $419.99 | 2021-2025 | Amvuttra, Onpattro |
| Exact Sciences Corporation | $292.78 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $268.13 | 2022-2023 | |
| Amarin Pharma, INC. | $241.33 | 2021-2023 | |
| Redhill Biopharma INC. | $217.53 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $195.41 | 2021-2024 | Linzess |
| Corcept Therapeutics | $178.09 | 2025 | Korlym |
| Abbott Laboratories | $162.01 | 2024-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $148.40 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.09 | 2023-2025 | Xifaxan |
| Inspire Medical Systems, INC. | $128.67 | 2024-2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $124.99 | 2025 | Rexulti |
| Scpharmaceuticals INC. | $123.55 | 2023-2025 | |
| Lexicon Pharmaceuticals, INC. | $121.01 | 2023-2024 | Inpefa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $114.49 | 2025 | Caplyta |
| Heartflow, INC. | $88.47 | 2024-2025 | |
| Astellas Pharma US INC | $78.76 | 2024-2025 | Veozah |
| Irhythm Technologies, INC. | $74.92 | 2022 | |
| Bridgebio Pharma, INC. | $66.28 | 2025 | Attruby |
| Scilex Pharmaceuticals INC. | $55.93 | 2023 | Ztlido |
| Lundbeck LLC | $53.58 | 2025 | Rexulti |
| Atricure, INC. | $52.60 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Impulse Dynamics (USA) INC. | $51.18 | 2022 | |
| Gilead Sciences, INC. | $42.62 | 2025 | |
| Medtronic, INC. | $41.40 | 2024 | Corevalve Evolut R |
| Genentech USA, INC. | $34.63 | 2024 | Xolair |
| Ardelyx, INC. | $34.26 | 2024 | Ibsrela |
| Photonicare INC | $33.03 | 2025 | Otosight Middle Ear Scope |
| Axsome Therapeutics, INC. | $27.59 | 2025 | Symbravo |
| Arbor Pharmaceuticals, INC. | $27.13 | 2021 | |
| Sumitomo Pharma America, INC. | $27.10 | 2025 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $25.00 | 2025 | Gvoke Hypopen |
| Cvrx, INC. | $22.06 | 2023 | Barostim Neo System |
| Viiv Healthcare Company | $21.87 | 2023 | Apretude |
| Kowa Pharmaceuticals America, INC. | $21.03 | 2022 | |
| Vanda Pharmaceuticals INC. | $19.13 | 2025 | Fanapt |
| Intra-Sana Laboratories | $17.83 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Baxter Healthcare | $17.00 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $16.64 | 2023 | Arcalyst |
| Mannkind Corporation | $16.27 | 2025 | |
| Phadia US INC. | $15.94 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $15.42 | 2025 | Neffy |
| Teva Pharmaceuticals USA, INC. | $15.05 | 2022 | |
| Currax Pharmaceuticals LLC | $13.90 | 2024 | Contrave |
| Dexcom, INC. | $13.27 | 2024 | Dexcom G6 Transmitter |
| Vivaquant INC, Dba Rhythm Express | $11.56 | 2025 | Rhythm Express |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.51 | 2022 | |
| Tms Neurohealth Centers INC. | $10.77 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Tavares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.